Antibiotic Resistance Market Size, Share, and Growth Forecast for 2025 - 2032

Table of Content

1. Executive Summary
   1. Global Antibiotic Resistance Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
   3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Regulatory Landscape
   2. Disease Epidemiology
   3. Pipeline Analysis
   4. Product Adoption Analysis
   5. Value Chain Analysis
   6. Key Promotional Strategies by Manufacturers
   7. PESTLE Analysis
   8. Porter’s Five Force Analysis
4. Global Antibiotic Resistance Market Outlook:
   1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2024
      2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
   3. Global Antibiotic Resistance Market Outlook: Drug Class
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Drug Class, 2019 - 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 - 2032
         1. Beta Lactam Antibiotic
         2. Tetracyclines
         3. Lipoglycopeptides
         4. Combination Therapies
         5. Cephalosporins
         6. Oxazolidinones
         7. Others
      4. Market Attractiveness Analysis: Drug Class
   4. Global Antibiotic Resistance Market Outlook: Pathogen
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Pathogen, 2019 - 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen, 2025 - 2032
         1. Staphylococcus aureus
         2. Streptococcus pneumonia
         3. Vancomycin- resistant Enterococcus
         4. Neisseria gonorrhoeae
         5. Pseudomonas aeruginosa
         6. Escherichia coli
         7. Mycobacterium tuberculosis
         8. Acinetobacter
         9. Clostridium difficile
         10. Others
      4. Market Attractiveness Analysis: Pathogen
   5. Global Antibiotic Resistance Market Outlook: Disease
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Disease, 2019 - 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Disease, 2025 - 2032
         1. Community Acquired Bacterial Pneumonia (CABP)
         2. Hopitals Acquired Bacterial Pneumonia/ Ventilator (HABP/VABP)
         3. Complicated Urinary Tract Infections (CUTI)
         4. Complicated Intra- Abdominal Infections (CIAI)
         5. Blood Stream Infections (BSI)
         6. Abdominal Infection and Diarohhea (Clostridium difficile infections (CDI) & Shigella)
         7. Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
         8. Others
      4. Market Attractiveness Analysis: Disease
   6. Global Antibiotic Resistance Market Outlook: Mechanism of Action
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Mechanism of Action, 2019 - 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Mechanism of Action, 2025 - 2032
         1. Cell Wall Synthesis Inhibitors
         2. Protein Synthesis Inhibitors
         3. DNA Synthesis Inhibitors
         4. RNA Synthesis Inhibitors
         5. Others
      4. Market Attractiveness Analysis: Mechanism of Action
   7. Global Antibiotic Resistance Market Outlook: Distribution Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2019 - 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
         1. Hospitals Pharmacies
         2. Retail Pharmacies
         3. Online Pharmacies
      4. Market Attractiveness Analysis: Distribution Channel
5. Global Antibiotic Resistance Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2024
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
6. North America Antibiotic Resistance Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Pathogen
      4. By Disease
      5. By Mechanism of Action
      6. By Distribution Channel
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Beta Lactam Antibiotic
      2. Tetracyclines
      3. Lipoglycopeptides
      4. Combination Therapies
      5. Cephalosporins
      6. Oxazolidinones
      7. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen, 2025 - 2032
      1. Staphylococcus aureus
      2. Streptococcus pneumonia
      3. Vancomycin- resistant Enterococcus
      4. Neisseria gonorrhoeae
      5. Pseudomonas aeruginosa
      6. Escherichia coli
      7. Mycobacterium tuberculosis
      8. Acinetobacter
      9. Clostridium difficile
      10. Others
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Disease, 2025 - 2032
      1. Community Acquired Bacterial Pneumonia (CABP)
      2. Hospital Acquired Bacterial Pneumonia/ Ventilator (HABP/VABP)
      3. Complicated Urinary Tract Infections (CUTI)
      4. Complicated Intra- Abdominal Infections (CIAI)
      5. Blood Stream Infections (BSI)
      6. Abdominal Infection and Diarrhea (Clostridium difficile infections (CDI) & Shigella)
      7. Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
      8. Others
   7. Current Market Size (US$ Mn) Analysis and Forecast, By Mechanism of Action, 2025 - 2032
      1. Cell Wall Synthesis Inhibitors
      2. Protein Synthesis Inhibitors
      3. DNA Synthesis Inhibitors
      4. RNA Synthesis Inhibitors
      5. Others
   8. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
   9. Market Attractiveness Analysis
7. Europe Antibiotic Resistance Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Pathogen
      4. By Disease
      5. By Mechanism of Action
      6. By Distribution Channel
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Beta Lactam Antibiotic
      2. Tetracyclines
      3. Lipoglycopeptides
      4. Combination Therapies
      5. Cephalosporins
      6. Oxazolidinones
      7. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen, 2025 - 2032
      1. Staphylococcus aureus
      2. Streptococcus pneumonia
      3. Vancomycin- resistant Enterococcus
      4. Neisseria gonorrhoeae
      5. Pseudomonas aeruginosa
      6. Escherichia coli
      7. Mycobacterium tuberculosis
      8. Acinetobacter
      9. Clostridium difficile
      10. Others
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Disease, 2025 - 2032
      1. Community Acquired Bacterial Pneumonia (CABP)
      2. Hospital Acquired Bacterial Pneumonia/ Ventilator (HABP/VABP)
      3. Complicated Urinary Tract Infections (CUTI)
      4. Complicated Intra- Abdominal Infections (CIAI)
      5. Blood Stream Infections (BSI)
      6. Abdominal Infection and Diarrhea (Clostridium difficile infections (CDI) & Shigella)
      7. Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
      8. Others
   7. Current Market Size (US$ Mn) Analysis and Forecast, By Mechanism of Action, 2025 - 2032
      1. Cell Wall Synthesis Inhibitors
      2. Protein Synthesis Inhibitors
      3. DNA Synthesis Inhibitors
      4. RNA Synthesis Inhibitors
      5. Others
   8. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
   9. Market Attractiveness Analysis
8. East Asia Antibiotic Resistance Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Pathogen
      4. By Disease
      5. By Mechanism of Action
      6. By Distribution Channel
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Beta Lactam Antibiotic
      2. Tetracyclines
      3. Lipoglycopeptides
      4. Combination Therapies
      5. Cephalosporins
      6. Oxazolidinones
      7. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen, 2025 - 2032
      1. Staphylococcus aureus
      2. Streptococcus pneumonia
      3. Vancomycin- resistant Enterococcus
      4. Neisseria gonorrhoeae
      5. Pseudomonas aeruginosa
      6. Escherichia coli
      7. Mycobacterium tuberculosis
      8. Acinetobacter
      9. Clostridium difficile
      10. Others
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Disease, 2025 - 2032
      1. Community Acquired Bacterial Pneumonia (CABP)
      2. Hospital Acquired Bacterial Pneumonia/ Ventilator (HABP/VABP)
      3. Complicated Urinary Tract Infections (CUTI)
      4. Complicated Intra- Abdominal Infections (CIAI)
      5. Blood Stream Infections (BSI)
      6. Abdominal Infection and Diarrhea (Clostridium difficile infections (CDI) & Shigella)
      7. Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
      8. Others
   7. Current Market Size (US$ Mn) Analysis and Forecast, By Mechanism of Action, 2025 - 2032
      1. Cell Wall Synthesis Inhibitors
      2. Protein Synthesis Inhibitors
      3. DNA Synthesis Inhibitors
      4. RNA Synthesis Inhibitors
      5. Others
   8. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
   9. Market Attractiveness Analysis
9. South Asia & Oceania Antibiotic Resistance Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Pathogen
      4. By Disease
      5. By Mechanism of Action
      6. By Distribution Channel
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Beta Lactam Antibiotic
      2. Tetracyclines
      3. Lipoglycopeptides
      4. Combination Therapies
      5. Cephalosporins
      6. Oxazolidinones
      7. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen, 2025 - 2032
      1. Staphylococcus aureus
      2. Streptococcus pneumonia
      3. Vancomycin- resistant Enterococcus
      4. Neisseria gonorrhoeae
      5. Pseudomonas aeruginosa
      6. Escherichia coli
      7. Mycobacterium tuberculosis
      8. Acinetobacter
      9. Clostridium difficile
      10. Others
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Disease, 2025 - 2032
      1. Community Acquired Bacterial Pneumonia (CABP)
      2. Hospital Acquired Bacterial Pneumonia/ Ventilator (HABP/VABP)
      3. Complicated Urinary Tract Infections (CUTI)
      4. Complicated Intra- Abdominal Infections (CIAI)
      5. Blood Stream Infections (BSI)
      6. Abdominal Infection and Diarrhea (Clostridium difficile infections (CDI) & Shigella)
      7. Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
      8. Others
   7. Current Market Size (US$ Mn) Analysis and Forecast, By Mechanism of Action, 2025 - 2032
      1. Cell Wall Synthesis Inhibitors
      2. Protein Synthesis Inhibitors
      3. DNA Synthesis Inhibitors
      4. RNA Synthesis Inhibitors
      5. Others
   8. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
   9. Market Attractiveness Analysis
10. Latin America Antibiotic Resistance Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Drug Class
       3. By Pathogen
       4. By Disease
       5. By Mechanism of Action
       6. By Distribution Channel
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 - 2032
       1. Beta Lactam Antibiotic
       2. Tetracyclines
       3. Lipoglycopeptides
       4. Combination Therapies
       5. Cephalosporins
       6. Oxazolidinones
       7. Others
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen, 2025 - 2032
       1. Staphylococcus aureus
       2. Streptococcus pneumonia
       3. Vancomycin- resistant Enterococcus
       4. Neisseria gonorrhoeae
       5. Pseudomonas aeruginosa
       6. Escherichia coli
       7. Mycobacterium tuberculosis
       8. Acinetobacter
       9. Clostridium difficile
       10. Others
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Disease, 2025 - 2032
       1. Community Acquired Bacterial Pneumonia (CABP)
       2. Hospital Acquired Bacterial Pneumonia/ Ventilator (HABP/VABP)
       3. Complicated Urinary Tract Infections (CUTI)
       4. Complicated Intra- Abdominal Infections (CIAI)
       5. Blood Stream Infections (BSI)
       6. Abdominal Infection and Diarrhea (Clostridium difficile infections (CDI) & Shigella)
       7. Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
       8. Others
    7. Current Market Size (US$ Mn) Analysis and Forecast, By Mechanism of Action, 2025 - 2032
       1. Cell Wall Synthesis Inhibitors
       2. Protein Synthesis Inhibitors
       3. DNA Synthesis Inhibitors
       4. RNA Synthesis Inhibitors
       5. Others
    8. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
       1. Hospitals Pharmacies
       2. Retail Pharmacies
       3. Online Pharmacies
    9. Market Attractiveness Analysis
11. Middle East & Africa Antibiotic Resistance Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Drug Class
       3. By Pathogen
       4. By Disease
       5. By Mechanism of Action
       6. By Distribution Channel
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2025 - 2032
       1. Beta Lactam Antibiotic
       2. Tetracyclines
       3. Lipoglycopeptides
       4. Combination Therapies
       5. Cephalosporins
       6. Oxazolidinones
       7. Others
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Pathogen, 2025 - 2032
       1. Staphylococcus aureus
       2. Streptococcus pneumonia
       3. Vancomycin- resistant Enterococcus
       4. Neisseria gonorrhoeae
       5. Pseudomonas aeruginosa
       6. Escherichia coli
       7. Mycobacterium tuberculosis
       8. Acinetobacter
       9. Clostridium difficile
       10. Others
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Disease, 2025 - 2032
       1. Community Acquired Bacterial Pneumonia (CABP)
       2. Hospital Acquired Bacterial Pneumonia/ Ventilator (HABP/VABP)
       3. Complicated Urinary Tract Infections (CUTI)
       4. Complicated Intra- Abdominal Infections (CIAI)
       5. Blood Stream Infections (BSI)
       6. Abdominal Infection and Diarrhea (Clostridium difficile infections (CDI) & Shigella)
       7. Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
       8. Others
    7. Current Market Size (US$ Mn) Analysis and Forecast, By Mechanism of Action, 2025 - 2032
       1. Cell Wall Synthesis Inhibitors
       2. Protein Synthesis Inhibitors
       3. DNA Synthesis Inhibitors
       4. RNA Synthesis Inhibitors
       5. Others
    8. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
       1. Hospitals Pharmacies
       2. Retail Pharmacies
       3. Online Pharmacies
    9. Market Attractiveness Analysis
12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. Thermo Fisher Scientific, Inc.
          1. Overview
          2. Segments and Products
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Merck KgaA
       3. Bio-Rad Laboratories, Inc.
       4. Takara Bio, Inc.
       5. QIAGEN N.V.
       6. Pall Corporation
       7. Eppendorf Corporate
       8. Tarsons Products PVT. LTD.
       9. Applied Biological Materials Inc.
       10. Greiner AG
       11. Brooks Life Sciences
       12. Corning Incorporated
       13. Cytiva
       14. PerkinElmer
13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations